Month: August 2024

                                                                                                                 20 August 2024                                                                                                                 Announcement No. 69/2024 Interim Financial Report, H1 2024 On August 20, 2024, the Supervisory Board has approved the Interim Financial Report, H1 2024 of Jyske Realkredit A/S. Please see the attached file. Yours sincerely,Jyske Realkredit A/S Carsten Tirsbæk MadsenCEO Direct phone (+45) 89 89 90 50E-mail: ctm@jyskerealkredit.dk Web: jyskerealkredit.dk Please observe that the Danish version of this announcement prevails. Attached files:Interim Financial Report of Jyske Realkredit H1 2024.pdfAttachmentInterim Financial Report of Jyske Realkredit H1 2024

Net interest income rose 5% to DKK 4,877m (H1 2023: DKK 4,639m) Core income rose 4% to DKK 6,828m (H1 2023: DKK 6,573m) Core expenses rose 6% to DKK 3,160m (H1 2023: DKK 2,974m) Loan impairment charges amounted to an expense of DKK 95m (H1 2023: DKK 109m) Net profit was up by 5% to DKK 2,623m (H1 2023: DKK 2,488m) Capital ratio at 21.9%, of this common equity tier 1 capital ratio at 16.6% (H1 2023: 20.3% and 16.1%, respectively) Net profit is expected to be in the upper half of the previously announced range of DKK 4.3bn-5.1bn in 2024 Organisational change and appointment to the Group Executive Board Successful IT migration of PFA Bank from BEC to Bankdata Share buy-back programme of up to DKK 1.5bn launched on 3 June 2024Summary ”In the first half of 2024, net profit was up 5% due to continued solid operations and the higher interest-rate...

Highlights On 22 April 2024 we announced that we shipped the first 10 μm multi-layer Solid-State Lithium Batteries (SSLBs) to one of our strategic partners for testing according to a pre-committed agreement.   On 27 June 2024 we announced delivery of samples to a customer within the Global Fortune 500 medical-device company in line with the evaluation agreement signed and announced on 25 October 2023.   Close to achieving our targets for energy density (Wh/L), charge cycles, production- and cycling-yield.    There have been several groundbreaking innovations making the production process simpler and more efficient than we had originally foreseen, for which we are seeking patent protection.  Our most recent mAh battery device characterization demonstrates a very high pulse current capability, up to 12.5C on demanding Bluetooth measurement...

9M 2023/24Interim financial results, 9M 2023/241 October 2023 – 30 June 2024 Coloplast delivered 8% organic growth and an EBIT margin1) of 27% in Q3, with 11% growth in absolute EBIT1). Reported revenue in DKK grew 13% which includes 4%-points contribution from Kerecis (underlying growth of around 35%).Organic growth rates by business area: Ostomy Care 8%, Continence Care 8%, Voice and Respiratory Care 11%, Advanced Wound Care 13% (Advanced Wound Dressings 13%) and Interventional Urology 2%. Growth in Chronic Care was broad-based across regions and includes an improvement in growth in the US Ostomy Care business. Continence Care growth was driven by intermittent catheters, including significant contribution from the male LujaTM catheter. Launch of the female Luja catheter* is ongoing and has received positive customer feedback. Voice...

 Trifork Group AGCompany announcement no. 30/2024Schindellegi, Switzerland – 20 August 2024Interim Financial Report for the second quarter and half year ending 30 June 2024Trifork Group reports Q2 revenue growth of 0.8% in the core business Second quarter 2024Trifork GroupIn Q2 2024, Trifork Group revenue amounted to EURm 52.5, a decrease of 5.0% from Q2 2023. In the quarter, Trifork had EURm 3.2 less revenue from the more volatile and non-core hardware and third-party licenses compared to Q2 2023. Adjusted for this, Group revenue growth was 0.8% in Q2 2024. Trifork Group adjusted EBITDA amounted to EURm 5.8, corresponding to 11.0% margin. Special items of EUR 0.05m were recorded. Trifork Group EBIT amounted to EURm 1.9, corresponding to 3.6% EBIT margin. Trifork Group net income amounted to EURm 1.3.Trifork SegmentIn...

20 August 2024 Icelandic Salmon is the parent company of Arnarlax, and other subsidiaries involved in salmon farming and processing in Iceland. The companies are collectively referred to as “Icelandic Salmon” or the “Group”. Operations In the second quarter 2024, Icelandic Salmon harvested 700 tonnes compared to 88 tonnes in the same quarter last year. Harvesting volumes have remained low as the Group has prioritised growing biological assets and the volume also reflects the seasonal variation in growth due to temperatures. The biological challenges seen in the beginning of the year continued to impact the Group’s operation in the second quarter, but various corrective measures implemented are beginning to show positive effects. Some biological irregularities continued in the second quarter, and a reassessment of...

Operational EBIT for Norway1 was at NOK 1,466 million for the second quarter 2024. Harvest volume was 44,100 tonnes and operational EBIT per kg was NOK 33.2. Operational EBIT the Group was NOK 1,393 million for the second quarter. Harvest volume was 44,800 tonnes and operational EBIT per kg was NOK 31.1. The Fish Farming segment in Norway showed improved biological performance, but harsh winter conditions and extreme weather earlier in the year continued to negatively impact the superior share and price achievement, particularly for Farming Northern Norway. Sales and Industry continued to demonstrate its efficient and flexible operational set-up. The contract share was 46 per cent, which combined with high spot prices resulted in negative contribution. Icelandic Salmon reported high cost due to continued biological challenges in the quarter...